Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gepotidacin in ABSSSI
NCT02045797Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gepotidacin in acute bacterial skin and skin structure infection (ABSSSI), sponsored by GSK. Started Mar 2014; status: completed.
02
Drugs
gepotidacin
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT02045797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045797.